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Many neurons have limited capacity to regenerate
their axons after injury. Neurons in the mammalian
central nervous system do not regenerate, and even
neurons in the peripheral nervous system often fail
to regenerate to their former targets. This failure is
likely due in part to pathways that actively restrict
regeneration; however, only a few factors that limit
regeneration are known. Here, using single-neuron
analysis of regeneration in vivo, we show that
Notch/lin-12 signaling inhibits the regeneration of
mature C. elegans neurons. Notch signaling sup-
presses regeneration by acting autonomously in the
injured cell to prevent growth cone formation. The
metalloprotease and gamma-secretase cleavage
events that lead to Notch activation during develop-
ment are also required for its activity in regeneration.
Furthermore, blocking Notch activation immediately
after injury improves regeneration. Our results define
a postdevelopmental role for the Notch pathway as
a repressor of axon regeneration in vivo.
INTRODUCTION
The ability of an injured axon to regenerate varies widely
between neurons and is regulated by both negative and positive
signaling pathways (Filbin, 2008; McGee and Strittmatter, 2003;
Rossi et al., 2007; Yiu and He, 2006). For example, neuronal
receptors that respond to myelin-derived factors—including
NogoR (Fournier et al., 2001) and PirB (Atwal et al., 2008)—inhibit
axon regeneration by regulating the neuronal cytoskeleton. The
dual phosphatase and tensin homolog (PTEN) reduces regen-
eration in both the mammalian central nervous system and
peripheral nervous system, at least in part by limiting mTor
activity and protein synthesis (Christie et al., 2010; Park et al.,
2008). SOCS3 inhibits regeneration by negatively regulating
JAK-STAT signaling and affecting gene transcription (Smith
et al., 2009). Such inhibitory pathways are attractive candidates
for therapy after nerve damage or disease. However, only a few
factors that limit regeneration in vivo are known.
The Notch signaling pathway is a highly conserved signal
transduction pathway that controls inductive cell-fate decisions
and differentiation during metazoan development (Artavanis-
Tsakonas et al., 1999; Fortini, 2009; Priess, 2005) and also regu-268 Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc.lates the development of postmitotic neurons (Berezovska
et al., 1999; Franklin et al., 1999; Hassan et al., 2000; Redmond
et al., 2000; Sestan et al., 1999). No function for Notch signaling
in axon regeneration has been described. Here, we identify
Notch signaling as an intrinsic inhibitor of nerve regeneration
in mature C. elegans neurons and show that regeneration is
improved when Notch signaling is genetically disrupted or
pharmacologically inhibited after nerve injury.RESULTS
Notch/lin-12 Inhibits Regeneration
C. elegans neurons whose axons are severed by a pulsed laser
can respond by regenerating (Yanik et al., 2004). Successful
axon regeneration is characterized by a postinjurymorphological
transition in which severed axons produce a stable growth cone
and begin regenerative growth. In neurons that fail to success-
fully regenerate, the axon stump appears healthy but quiescent
(Figure 1A). Long-term imaging has demonstrated that these
stumps do not initiate growth cones, even transitory ones
(Hammarlund et al., 2009). Consistent with previous results, we
found that axons in wild-type animals often fail to regenerate:
only 68% of axons regenerated, whereas 32% of axons failed
to successfully regenerate (Figure 1C; see Table S1 available
online for full genotypes and data). The failure of many neurons
to regenerate suggests that regeneration may be limited by
inhibitory pathways.
To determine the function of Notch signaling in axon regener-
ation, we characterized regeneration in Notch mutant animals
after laser axotomy (see Experimental Procedures). During
development, Notch functions to limit neurite extension (Bere-
zovska et al., 1999; Franklin et al., 1999; Hassan et al., 2000;
Redmond et al., 2000; Sestan et al., 1999), raising the possibility
that Notch signaling may inhibit regeneration of the mature
nervous system. Notch signaling in C. elegans is mediated by
two transmembrane Notch proteins, encoded by the genes
lin-12 and glp-1 (Austin and Kimble, 1989; Yochem and Green-
wald, 1989; Yochem et al., 1988). The GABA nervous system
of homozygous Notch/lin-12(n941) null mutants was indistin-
guishable from wild-type animals, except in the vulval region,
where Notch/lin-12 signaling is required for normal vulval
morphogenesis (Figure 1B) (Greenwald et al., 1983). After
laser surgery, however, axons in Notch/lin-12 loss-of-function
animals regenerated significantly better than wild-type (Fig-
ure 1C). In Notch/lin-12 loss-of-function animals, nearly all axons
successfully regenerated, and failure of regeneration was re-
duced more than 2-fold, to 12%. In addition, two Notch/lin-12
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Figure 1. Notch Signaling Inhibits Nerve Regeneration
(A) Axon regeneration in C. elegans GABA neurons. Some injured axons
regenerate (left panels), whereas some do not (right panels). Arrowheads in
diagrams indicate distal axon fragments; stars indicate cell bodies.
Neuron
Notch Signaling Inhibits Axon Regenerationgain-of-function alleles, lin-12(n137) and lin-12(n137n460), both
of which have increased Notch/lin-12 signaling (Greenwald and
Seydoux, 1990), had reduced regeneration. Notch/lin-12 also
inhibited regeneration of cholinergic motor neurons (Figure 1D).
By contrast, Notch/glp-1 did not affect regeneration (Figure 1E).
Thus, Notch/lin-12 is a potent inhibitor of nerve regeneration.
Notch/lin-12 Inhibits Growth Cone Formation
after Nerve Injury
Previously, we showed that growth cone initiation is a critical
step of regeneration. Neurons that fail to regenerate do not
initiate growth cones after injury, but rather remain indefinitely
as quiescent stumps. Conversely, neurons that do regenerate
initiate growth cones, typically between 200 and 600 min after
injury (Hammarlund et al., 2009). Because loss of Notch
increases overall regeneration, we hypothesized that Notch
acts to restrict growth cone initiation after injury and that loss
of Notch would result in increased growth cone initiation. To
test this idea, we examined neurons 4 and 6 hr after severing
their axons (Figures 2A and 2B). Consistent with previous results,
in wild-type animals, only a small percentage of axons had
initiated growth cones at these early time points (6 hr: 9/113
axons with growth cones, 8%). By contrast, Notch/lin-12mutant
animals displayed a significant increase in growth cone initiation
at 6 hr after surgery (19/82 axons with growth cones, 23%;
p = 0.004). Thus, releasing Notch inhibition results in earlier
growth cone formation, suggesting that Notch inhibits regenera-
tion by preventing the initiation of growth cones.
Notch/lin-12 Affects Functional Recovery
after Nerve Injury
Functional regeneration requires completion of the regeneration
program, restoring connectivity between injured neurons and
their former targets. To determine whether Notch inhibition of
regeneration affects functional regeneration, we first measured
the ability of injured axons to grow all the way back to their former
position at the dorsal nerve cord (‘‘full regeneration’’) in wild-type
and mutant animals. We found that Notch/lin-12mutant animals
displayed significantly more full regeneration than wild-type
(Figure 2C; wild-type: 8/30 axons with full regeneration, 27%;
lin-12(n941): 19/32, 59%; p = 0.01). Thus, using a morphological
assay, release of Notch inhibition allows more injured axons to
reach their target. To determine whether Notch can also affect
functional regeneration, we used a behavioral assay for GABA
neuron function. The GABA motor neurons make inhibitory
connections onto body wall muscles. These neurons are partic-
ularly important for backward movement, and animals that lack
GABA neuron function cannot move backward when prodded
on the nose (Schuske et al., 2004). It has been demonstrated
that severing all GABA neurons results in characteristic back-
ward movement defects and that normal behavior is recovered(B) GABA neurons in wild-type and in Notch/lin-12 null mutants. Arrowheads
indicate commissures; stars indicate cell bodies. DNC, dorsal nerve cord;
VNC, ventral nerve cord.
(C) Notch/lin-12 inhibits regeneration of GABA neurons.
(D) Notch/lin-12 inhibits regeneration of acetylcholine neurons.
(E) Notch/glp-1 does not inhibit regeneration of GABA neurons.
Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc. 269
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Figure 2. Notch Affects Growth Cone Formation
and Behavioral Recovery
(A) Representative axons that have not formed a growth
cone (left) or have formed a growth cone (right) at 6 hr after
injury.
(B) Growth cone formation after injury in wild-type and
Notch/lin-12 null mutants.
(C) Notch/lin-12 inhibits complete morphological regen-
eration.
(D) Notch/lin-12 inhibits behavioral recovery after nerve
injury.
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Notch Signaling Inhibits Axon Regenerationas the neurons regenerate (Yanik et al., 2004). In order to assess
the effect of Notch/lin-12 activity on functional regeneration,
we assessed behavioral recovery in the gain-of-function allele
lin-12(n137), which has increased Notch signaling and
decreased regeneration (Figure 1C). (Notch/lin-12 null animals
have morphogenetic defects that make it impossible to assess
recovery of backward movement.) We cut all right-side GABA
motor neurons in wild-type and Notch gain-of-function mutants
and scored backward movement 24 hr after surgery (Figure 2D).
We found that, as previously described, most wild-type animals
showed robust behavioral recovery. By contrast, animals with
increased Notch signaling recovered poorly. These data provide
evidence in C. elegans for a signaling pathway that can affect
behavioral recovery after nerve injury and demonstrate that
Notch can act to limit functional as well as morphological
regeneration.
Notch/lin-12 Inhibits Regeneration via a Canonical
Activation Mechanism
Notch activation in C. elegans involves sequential cleavage of
the Notch protein, first by a transmembrane ADAM metallopro-
tease (known as ‘‘site 2 cleavage’’), followed by intramembrane
cleavage by the intracellular gamma-secretase complex (‘‘site 3
cleavage’’) (Fortini, 2009; Gordon et al., 2008). These cleavages270 Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc.release the Notch intracellular domain (NICD)
into the cytoplasm (Figure 3A). To determine
whether Notch inhibits regeneration via its
canonical activation pathway, we first tested
regeneration in mutant animals that lack func-
tional ADAM metalloproteases. In C. elegans,
two genes encode ADAM metalloproteases
that mediate Notch signaling: ADAM10/sup-17
and ADAM17/adm-4 (Jarriault and Greenwald,
2005; Tax et al., 1997; Wen et al., 1997). Axon
regeneration in loss-of-function mutants in
ADAM10/sup-17(n316) was similar to mutants
that disrupt Notch/lin-12 itself: loss of
ADAM10/sup-17 significantly improved regen-
eration (Figure 3B). A loss-of-function mutant
in ADAM17/adm-4 did not affect regeneration
(Figure 3C). Thus, ADAM10/sup-17 inhibits
axon regeneration.
Metalloproteases have multiple cellular
targets. To determine whether Notch/lin-12 is
the specific target of ADAM10/sup-17 in axonregeneration, we analyzed double-mutant animals. If ADAM10/
sup-17 has other relevant cellular targets besides Notch/
lin-12, the double mutant should have higher regeneration
than either single mutant. Because both single mutants already
have regeneration that approaches 100%, we conducted this
analysis by examining growth cone initiation at the 6 hr time
point. We found that ADAM10/sup-17 mutants, like Notch/
lin-12 mutants, have increased growth cone initiation at 6 hr
relative to wild-type (Figure 3D). Animals that lacked both
Notch/lin-12 and ADAM10/sup-17 did not display any additional
increase in growth cone formation. Together, these data
suggest that Notch/lin-12 is the major target of ADAM10/
sup-17 in axon regeneration. Next, we examined the converse
question: whether Notch/lin-12 can use alternate activation
mechanisms that are independent of ADAM10/sup-17. We
tested whether ADAM10/sup-17 is required for all the inhibitory
effects of gain-of-function Notch/lin-12(n137n460) on regen-
eration. We found that the gain-of-function Notch/lin-12 allele
failed to inhibit regeneration in double mutants that also lacked
ADAM10/sup-17 (Figure 3B). Thus, the inhibition of regenera-
tion by Notch/lin-12 requires metalloprotease processing by
ADAM10/sup-17. Together, these data demonstrate that
Notch/lin-12 and ADAM10/sup-17 function together to inhibit
regeneration.
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Figure 3. Notch Inhibits Regeneration via a Canon-
ical Activation Pathway
(A) Notch signaling in C. elegans.
(B) ADAM10/sup-17 inhibits regeneration and is required
for Notch/lin-12 to inhibit regeneration.
(C) ADAM17/adm-4 does not inhibit regeneration in GABA
neurons.
(D) Notch/lin-12 and ADAM10/sup-17 function together to
inhibit regeneration.
(E) Presenilin/sel-12 and hop-1 inhibit regeneration.
(F) Notch protein domains and design of the GFP-tagged
NICD construct (NCID-GFP).
(G) NICD-GFP is localized to nuclei in GABA neurons.
Green, NICD-GFP; purple, soluble mCherry; white, co-
localization. Arrows indicate cell bodies; arrowheads
indicate commissures.
(H) Expression of NICD-GFP in wild-type animals inhibits
regeneration.
(I) Abl/abl-1 does not affect regeneration in GABA neurons.
(J) A weak allele of CSL/lag-1 does not affect regeneration
in GABA neurons. Bars in (B)–(E) and (H)–(J) show
percentage of axons that initiated regeneration; error bars
show 95% confidence interval (CI). *p < 0.05, **p < 0.01,
***p < 0.001 (See also Table S1.)
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Notch Signaling Inhibits Axon RegenerationTo investigate the function of the gamma-secretase complex
during axon regeneration, we tested regeneration in mutant
animals that lack presenilin, the catalytic component of the
gamma-secretase complex. Presenilin in C. elegans is encoded
by two genes, sel-12 and hop-1 (Levitan andGreenwald, 1995; Li
and Greenwald, 1997). We found that double-mutant sel-
12(ok2078); hop-1(ar179) animals, which lack functional gamma
secretase, were similar to Notch/lin-12 mutants: they displayed
significantly increased regeneration compared to wild-type
animals (Figure 3E). Thus, elimination of functional gamma sec-
retase has an effect similar to elimination of Notch/lin-12:
increased regeneration. Together, these data suggest thatNeuron 73, 26Notch/lin-12, ADAM10/sup-17, and gamma-
secretase/sel-12 and hop-1 comprise a linear
pathway that inhibits regeneration. Further,
because the function of ADAM10 and gamma
secretase is to liberate the NICD, they suggest
that inhibition of axon regeneration is specifi-
cally mediated by this domain of Notch.
The NICD is required for all known Notch
functions (Jarriault et al., 1995; Lieber et al.,
1993; Struhl et al., 1993). To test whether
NICD is sufficient to inhibit regeneration, we
constructed a green fluorescent protein (GFP)-
tagged version of the Notch/lin-12 intracellular
domain (NICD-GFP; Figure 3F). When this
construct was expressed in wild-type animals,
the NICD-GFP signal was concentrated in
a subcellular distribution consistent with nuclear
localization (Figure 3G). Expression of NICD-
GFP resulted in significantly reduced regenera-
tion compared to control (Figure 3H) and was
similar to regeneration in gain-of-function Notchmutants (Figure 1C). Thus, a canonical activation mechanism
culminating in active NICD mediates inhibition of regeneration
by Notch/lin-12.
NICD contains the CDC10/ankyrin repeats that mediate Notch
transcriptional activation, andmost Notch functions involve tran-
scriptional regulation. However, a transcription-independent
mechanism of Notch action has been described. In this tran-
scription-independent mechanism, NICD does not require its
CDC10/ankyrin repeats and acts via inhibiting the receptor tyro-
sine kinase Abl pathway (Giniger, 1998; Le Gall et al., 2008). To
determine whether this noncanonical mechanism is active in
limiting regeneration, we examined regeneration in Abl/abl-18–278, January 26, 2012 ª2012 Elsevier Inc. 271
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Figure 4. Notch/lin-12 Functions Cell Intrinsically to Limit Regener-
ation
(A) Mosaic animals allow identification of NICD-GFP-expressing individual
neurons.
(B) Notch/lin-12 NICD-GFP overexpression inhibits regeneration cell intrinsi-
cally.
(C) Notch/lin-12 overexpression in GABA neurons inhibits GABA neuron
regeneration.
(D) NICD expression in Notch/lin-12 mutants in GABA neurons inhibits GABA
neuron regeneration.
(E) Mosaic expression of ADAM10/sup-17 in GABA neurons, but not in muscle
or skin, inhibits GABA neuron regeneration.
(F) ADAM10/sup-17 overexpression in GABA neurons inhibits GABA neuron
regeneration.
(G) ADAM10/sup-17 overexpression in GABA neurons in Notch/lin-12 null
mutants does not inhibit GABA neuron regeneration.
(H) Notch/glp-1 NICD-mCh overexpression inhibits regeneration in GABA
neurons.
(I) ADAM/adm-4 overexpression inhibits regeneration in GABA neurons.
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272 Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc.mutant animals: if Notch inhibits regeneration by inhibiting Abl,
these mutants should have decreased regeneration. However,
regeneration in Abl/abl-1 mutant animals was not different from
wild-type controls (Figure 3I), suggesting that Abl signaling
does not function in regeneration and does not mediate the
inhibitory effects of Notch signaling. These data suggest that
Notch acts by regulating transcription. Typically, Notch signaling
regulates transcription via a CSL-family transcription factor; in
C. elegans, the single known Notch target is the CSL protein
lag-1 (Greenwald, 2005). To determine whether Notch/lin-12
acts via CSL/lag-1 to limit regeneration, we sought to test regen-
eration in CSL/lag-1 mutant animals. However, loss of lag-1 is
lethal, and viable alleles of lag-1 fail to block some known func-
tions of Notch/lin-12 signaling (Lambie and Kimble, 1991;
Solomon et al., 2008). We tested regeneration in the strongest
available viable allele (Qiao et al., 1995) and found that it did
not affect regeneration (Figure 3J). We conclude that Notch
signaling probably acts via a transcriptional mechanism, but
the identity of the transcriptional cofactor and the function of
CSL/lag-1 remain to be determined.Notch/lin-12 Acts Cell Intrinsically to Inhibit
Regeneration
Previous studies have identified factors that inhibit regeneration
by functioning in the injured neuron (such as the Nogo receptor
and PTEN) and factors that inhibit regeneration due to expres-
sion in the surrounding cells (such as myelin-derived factors
and chondroitin sulfate proteoglycans). Several results indicate
that Notch acts cell autonomously in the injured neuron to limit
regeneration. First, overexpression of the constitutively active
NICD-GFP under a GABA neuron-specific promoter inhibits
regeneration in the GABA neurons (Figures 3F–3H). Second,
we found that expressing the constitutively active NICD-GFP in
a mosaic manner inhibits regeneration only in the individual cells
that express NICD-GFP, whereas cells in the same animal that
were without the transgene were not inhibited. We expressed
NICD-GFP in an unstable transgene under the GABA-specific
Punc-47 promoter. We introduced this transgene into animals
that also expressed soluble mCherry in the GABA neurons
(Figure 4A). We used mCherry fluorescence to cut both NICD-
GFP(+) and NICD-GFP() axons and quantified axon regenera-
tion separately for each group. NICD-GFP(+) axons had signifi-
cantly decreased regeneration compared to control wild-type
animals (Figure 4B), similar to gain-of-function Notch/lin-12
mutant axons (Figure 1C). By contrast, NICD-GFP() axons
from the same animals had normal regeneration (Figure 4B).
Third, we observed a similar overall inhibition of regeneration
when we overexpressed full-length Notch/lin-12 cDNA only in
the GABA neurons (Figure 4C). Fourth, we found that NICD-
GFP is able to cell autonomously inhibit regeneration in animals
that otherwise lack Notch/lin-12. We expressed NICD-GFP only
in the GABA neurons of null Notch/lin-12 mutant animals. The
gross phenotype of this strain was identical to nontransgenic(J) Presenilin/sel-12 overexpression does not inhibit regeneration in GABA
neurons. Bars in (B)–(J) show percentage of axons that initiated regeneration;
error bars show 95%CI. *p < 0.05, **p < 0.01, ***p < 0.001. (See also Table S1.)
Neuron
Notch Signaling Inhibits Axon RegenerationNotch/lin-12 null mutants: animals had protruding vulvas and
were completely sterile. However, these animals had decreased
regeneration in their GABA neurons (Figure 4D), compared to
the increased regeneration normally found in Notch/lin-12
null mutants (Figure 1C). Together, these results suggest that
cell-autonomous Notch signaling is sufficient to inhibit axon
regeneration.
To determine whether intrinsic Notch signaling is necessary to
inhibit regeneration, we performed tissue-specific rescue of
ADAM10/sup-17. Regenerating GABA neurons contact only
two tissues: body-wall muscles and skin. ADAM10/sup-17 null
mutants have increased regeneration (Figure 3B). We found
that expression of wild-type ADAM10/sup-17 in muscles or
skin did not affect this phenotype. Only when wild-type
ADAM10/sup-17 was expressed in GABA neurons was regener-
ation inhibited back to wild-type levels (Figure 4E). Additionally,
we found that overexpression in wild-type animals of ADAM10/
sup-17 in the GABA neurons inhibits regeneration (Figure 4F).
Consistent with Notch/lin-12 being the relevant target of
ADAM10/sup-17, overexpression of ADAM10/sup-17 in Notch/
lin-12 null mutants does not inhibit regeneration (Figure 4G).
Taken together, these data demonstrate that Notch acts cell
autonomously to inhibit regeneration and establish that Notch
signaling is an intrinsic inhibitor of axon regeneration.
In C. elegans, Notch itself and the ADAM metalloprotease
that mediates Notch activation are encoded by two genes,
with overlapping but different functions (Figure 3A) (Jarriault
and Greenwald, 2005). However, only one Notch gene (Notch/
lin-12) and one ADAM (ADAM/sup-17) inhibit regeneration in
GABA neurons (Figures 1 and 3). Because Notch inhibition of
regeneration is cell autonomous, we tested whether the remain-
ing Notch components could also limit regeneration when
overexpressed in GABA neurons. We found that GABA-specific
overexpression of Notch/glp-1 NICD-mCh inhibited regenera-
tion (Figure 4H), similar to overexpression of Notch/lin-12
NICD-GFP (Figure 3H). GABA-specific overexpression of
ADAM/adm-4 also inhibited regeneration (Figure 4I), similar to
overexpression of ADAM/sup-17 (Figure 4F). By contrast,
GABA-specific overexpression of presenilin/sel-12 did not limit
regeneration (Figure 4J). Together, these data suggest that
activated Notch signaling in general inhibits regeneration.
Notch Signaling Functions at the Time of Injury
to Inhibit Regeneration
Notch signaling functions during development to regulate cell-
fate specification (Artavanis-Tsakonas et al., 1999; Fortini,
2009; Priess, 2005), axon guidance (Crowner et al., 2003), and
neurite extension (Franklin et al., 1999). Notch signaling is also
present in mature neurons: in C. elegans, for example, Notch
acts in mature neurons to regulate dauer decisions (Ouellet
et al., 2008), thermotaxis (Wittenburg et al., 2000), and locomo-
tory behavior (Chao et al., 2005). To determine when Notch
signaling acts to limit nerve regeneration, we employed a temper-
ature-sensitive allele of ADAM10/sup-17, sup-17(n1258ts) (Tax
et al., 1997). These animals have normal Notch signaling at the
permissive temperature of 15C but have reduced Notch
signaling at the restrictive temperature of 25C. The tempera-
ture-sensitive ADAM10/sup-17 animals regenerated like thewild-type at the permissive temperature but had increased
regeneration and fewer regeneration failures than the wild-type
when shifted to the nonpermissive temperature after surgery
(Figures 5A–5C). These data demonstrate that Notch signaling
is active after injury in mature neurons and that this postinjury
Notch signaling is necessary to limit regeneration.
Notch signaling can be blocked by pharmacological inhibition
of gamma secretase, and gamma-secretase inhibitors are under
active development for treatment of cancer and Alzheimer’s
disease (Dovey et al., 2001; Shih and Wang, 2007). Because
Notch signaling after nerve injury is required for suppression of
regeneration, we hypothesized that regeneration in wild-type
animals might be improved by drug inhibition of Notch signaling
after nerve injury. To test whether gamma-secretase inhibition
can increase regeneration, we employed the small molecule
N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl
ester (DAPT), which is a potent inhibitor of gamma-secretase
activity and Notch signaling (Geling et al., 2002). We performed
axotomy on wild-type animals and then immediately microin-
jected their pseudocoelom with either 100 mMDAPT or a control
solution (Figure 5D, immediate DAPT). Animals treated immedi-
ately with DAPT had increased regeneration and fewer regener-
ation failures than control animals (Figure 5E), similar to genetic
manipulations that reduce Notch signaling (Figure 1C). To
confirm that gamma secretase is the relevant target of DAPT,
we performed DAPT injection in double-mutant sel-12(ok2078);
hop-1(ar179) animals, which lack functional gamma secretase
and have increased regeneration (Figure 3E). DAPT injection in
these animals did not further increase regeneration, demon-
strating that DAPT acts by inhibiting gamma secretase (Fig-
ure 5F). These data show that Notch signaling is active in mature
neurons and that Notch signaling after injury is required to inhibit
regeneration. Furthermore, this experiment suggests that direct
microinjection after laser axotomy inC. elegans could be used to
test potential agents aimed at improving regeneration.
DAPT acts by inhibiting gamma secretase and blocking Notch
activation. DAPT injection immediately after injury prevents
Notch signaling from inhibiting regeneration. To determine the
temporal requirements for Notch activation after injury, we in-
jected animals with DAPT 2 hr after surgery (‘‘DAPT + 2 hr,’’ Fig-
ure 5D). These animals did not regenerate better than controls
(Figure 5G). Thus, by 2 hr after surgery, Notch is already suffi-
ciently activated to inhibit regeneration. Together, our data
demonstrate that Notch signaling is unable to inhibit regenera-
tion unless Notch is activated immediately following injury. It is
possible that this temporal requirement is because injury itself
activates Notch. Alternatively, activated Notch signals may
need to interact with other cellular events triggered by injury in
order to limit regeneration.
Individual Notch Ligands Are Not Required for Inhibition
of Regeneration
Notch signaling is activated by DSL-family ligands. To identify
the ligand that activates Notch inhibition of regeneration, we as-
sayed regeneration in all available DSL-family ligand mutants
(Table 1). Because Notch signaling inhibits regeneration, loss
of the ligand that activates Notch should result in increased
regeneration, similar to loss of Notch signaling itself (Figures 1Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc. 273
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Figure 5. Notch Signaling Functions at the Time of Injury to Inhibit
Regeneration, and Chemical Inhibition of Notch Improves Regener-
ation in Wild-Type Animals
(A) Temperature shift or control (no shift) was performed immediately after
axotomy.
(B) Temperature manipulations do not affect regeneration in wild-type animals.
(C) Regeneration is increased when temperature-sensitive ADAM10/sup-17
animals are shifted to the nonpermissive temperature after axotomy.
(D) DAPT in DMSO or control (DMSO) was injected immediately after axotomy
or after a 2 hr delay.
(E) Injecting DAPT immediately after axotomy increases regeneration.
(F) Injecting DAPT immediately after axotomy into sel-12; hop-1 mutant
animals does not increase regeneration.
(G) Injecting DAPT 2 hr after axotomy has no effect on regeneration. Bars in (B),
(C), (E), and (F) show percentage of axons that initiated regeneration; error bars
show 95% CI. *p < 0.05, **p < 0.01, ***p < 0.001. (See also Table S2.)
Neuron
Notch Signaling Inhibits Axon Regeneration
274 Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc.and 3). Surprisingly, however, no ligand mutant displayed
increased regeneration. Rather, all ligand mutants regenerated
at wild-type levels, with the single exception of DSL/lag-2, which
displayed decreased regeneration. We conclude that no single
ligand is necessary to activate Notch for inhibiting regeneration
(see Discussion).
Notch/lin-12 Signaling and the DLK-1 MAP Kinase
Pathway
The MAP kinase pathway defined by the MAP3K dlk-1
promotes regeneration by functioning in injured neurons at
the time of injury (Hammarlund et al., 2009; Yan et al., 2009).
Thus, both Notch signaling and the dlk-1 pathway act in the
same cell at the same time to regulate axon regeneration.
However, two lines of evidence suggest these two pathways
may regulate axon regeneration independently of one another
(Figure 6A). First, we determined that constitutive absence of
Notch signaling does not increase activity of the dlk-1 pathway.
We monitored dlk-1 pathway activity in Notch pathway mutants
by assessing expression of a cebp-1 fluorescent reporter
gene (Figure 6B). Expression of this reporter is increased about
6-fold in mutants that increase dlk-1 pathway activity (Yan
et al., 2009). However, reporter expression was not increased
in ADAM10/sup-17 mutants (which lack Notch signaling),
suggesting that Notch does not suppress regeneration by
constitutively inhibiting the dlk-1 pathway (Figure 6C). Consis-
tent with these data, blocking Notch signaling in aged animals
does not increase regeneration compared to aged wild-type
animals (Figure 6D). By contrast, dlk-1 overexpression can
restore regeneration in aged animals (Hammarlund et al.,
2009). Next, we determined that the DLK-1 pathway does not
regulate regeneration via Notch. We found that absence of
Notch signaling—which increases regeneration—is unable to
bypass the requirement for dlk-1. We examined regeneration
in dlk-1; sup-17 double mutants, which lack both Notch
signaling and dlk-1 signaling. These animals regenerated as
poorly as dlk-1 single mutants, suggesting that inhibition of
Notch is not the major effect of the dlk-1 pathway (Figure 6E).
Together, these experiments suggest that Notch and dlk-1
signaling may act independently to regulate regeneration. Alter-
natively, Notch may act at the time of injury to acutely limit
activity of the dlk-1 pathway.
Table 1. Individual Notch Ligands Are Not Required for Notch Function in Regeneration
Description Genotype Strain
Number of
Animals
Number of
Axons % Regeneration p Value
wild-type oxIs12 EG1285 111 323 69
wild-type juIs76 OH4121 33 113 73
lag-2 lag-2(q420)ts; oxIs12 XE1199 22 53 30 <0.0001
osm-11 osm-11(rt142); juIs76 XE1276 16 55 71 0.85
osm-7 osm-7(n1515); oxIs12 XE1418 18 47 66 0.7
osm-7 osm-7(tm2256); oxIs12 XE1419 21 46 72 0.73
apx-1 allele 1 apx-1(or22); oxIs12 Derived from XE1408 9 26 77 0.5
apx-1 allele 2 apx-1(or15); oxIs12 Derived from XE1407 9 25 76 0.5
dsl-1 dsl-1(ok810); oxIs12 XE1411 18 44 77 0.29
dsl-3 dsl-3(ok3411); oxIs12 XE1412 19 52 60 0.2
dsl-4 dsl-4(ok1020); juIs76 XE1413 13 32 84 0.2
dsl-5 dsl-5(ok588); oxIs12 XE1409 15 38 68 1.0
dsl-6 dsl-6(ok2265); oxIs12 XE1410 11 30 73 0.68
dos-1 dos-1(ok2398); oxIs12 XE1414 21 53 74 0.14
dos-2 dos-2(tm4515); oxIs12 XE1415 12 31 84 0.1
dos-3 dos-3(tm4899); oxIs12 XE1416 19 51 65 0.63
arg-1 arg-1(ok3127); juIs76 XE1417 19 49 84 0.162
apx-1 balanced strain 1 apx-1(or22)/nT1; oxIs12 XE1408 N/A
apx-1 balanced strain 2 apx-1(or15)/nT1; oxIs12 XE1407 N/A
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Our results identify a postdevelopmental role for Notch sig-
naling: inhibition of axon regeneration. Notch signaling inhibits
regeneration via a canonical activation pathway, involving
Notch/lin-12, the metalloprotease ADAM10/sup-17, and the
gamma-secretase complex. These factors release the NICD of
Notch/lin-12 into the cytoplasm. The NICD localizes to the
nucleus and is sufficient to inhibit regeneration, suggesting
that a nuclear function of the NICD mediates Notch inhibition
of regeneration. In the GABA neurons studied in this work, not
all Notch pathway components affect regeneration. Specifically,
the other C. elegans Notch, Notch/glp-1, and the other metallo-
protease that mediates Notch signaling, ADAM17/adm-4, do not
affect regeneration of the GABA neurons. However, both the
NICD of Notch/glp-1 and ADAM17/adm-4 inhibit regeneration
when overexpressed in GABA neurons. These data suggest
that the different effects of the endogenous Notch components
on axon regeneration are not due to different target specificities
or intracellular activation mechanisms. Rather, lack of expres-
sion of Notch/glp-1 and ADAM17/adm-4 in the GABA neurons
could account for the lack of endogenous inhibitory activity of
these genes. Consistent with this idea, Notch/glp-1 is expressed
in some postmitotic neurons, but not in GABA neurons (Ouellet
et al., 2008), and ADAM/adm-4 is not expressed in adult neurons
(Hunt-Newbury et al., 2007). Thus, Notch signaling can function
generally to restrict regeneration, at least in GABA neurons.
Notch signaling usually acts by regulating gene transcription
via a CSL-family transcription factor. Although we were unable
to demonstrate a role in inhibition of regeneration for the single
C. elegans CSL factor, CSL/lag-1, two lines of evidence suggestthat regulation of gene transcription may account for Notch’s
ability to inhibit regeneration. First, the Abl signaling pathway,
which mediates nontranscriptional function of the NICD (Giniger,
1998; Le Gall et al., 2008), does not regulate axon regeneration
(Figure 3I). Second, a GFP-tagged Notch/lin-12 NICD localizes
to the nucleus and inhibits regeneration (Figures 3F–3H), consis-
tent with a transcriptional function. Because Notch signaling
usually activates gene transcription (Greenwald, 2005), the
targets of Notch signaling in regeneration are likely to be factors
that themselves limit regeneration. Although no direct Notch
targets in mature C. elegans neurons are currently known,
some candidate genes have been identified (Singh et al., 2011;
Yoo et al., 2004). Identification of the relevant targets would
provide insight into the mechanism of Notch inhibition of regen-
eration and could also shed light on how Notch generally inhibits
the growth of postmitotic neurons (Berezovska et al., 1999;
Franklin et al., 1999; Redmond et al., 2000; Sestan et al., 1999).
How is Notch activated to inhibit regeneration? Our data
indicate that no single Notch ligand is required for this activation
(Table 1). However, it is possible that two or more ligands
function redundantly to mediate Notch activation. Alternatively,
Notch activation could occur via a ligand-independent mecha-
nism. In normal cellular contexts, DSL ligands activate Notch
by changing Notch’s relationship to the plasma membrane,
allowing ADAM cleavage to occur. It is possible that nerve injury
and consequent relaxation of plasma membrane tension alter
the conformation of Notch relative to the membrane and allow
ADAM cleavage of Notch even without ligand binding. Interest-
ingly, the DSL ligand DSL/lag-2 promotes regeneration, rather
than inhibiting it, because lag-2 mutants have decreased
regeneration (Table 1). It is possible that loss of lag-2 triggersNeuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc. 275
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Figure 6. Notch Regulates Regeneration Independently of the dlk-1
MAP Kinase Pathway
(A) Three models describing the relationship of Notch and dlk-1 signaling
during axon regeneration.
(B) Expression of a cebp-1 reporter in GABA neurons in the wild-type and in
ADAM10/sup-17 mutants. Arrowheads indicate commissures; stars indicate
cell bodies.
(C) Removing Notch signaling does not increase cebp-1 fluorescence in GABA
neurons. Bars show mean fluorescence; error bars show SEM.
(D) Blocking Notch activation immediately after injury does not improve
regeneration in aged animals.
(E) dlk-1 does not promote regeneration by inhibiting Notch. Bars show
percentage of axons that initiated regeneration; error bars show 95% CI. *p <
0.05, **p < 0.01, ***p < 0.001. (See also Table S3.)
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tion. These mechanisms could involve increased Notch sig-
naling, either via activation by a different ligand or by a ligand-
independent mechanism; alternatively, loss of lag-2 could trigger
Notch-independent inhibition of regeneration.
Our data demonstrate that Notch signaling regulates a very
early stage of regeneration: growth cone initiation (Figures 2A276 Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc.and 2B). To limit growth cone initiation, Notch must act soon
after injury. Consistent with this result, blocking Notch activation
at the time of injury is sufficient to prevent Notch from inhibiting
regeneration, whereas blocking activation 2 hr after injury does
not increase regeneration (Figures 5E and 5G). It is possible
that Notch is active in GABA neurons even before injury but
that continued activation is necessary because the down-
stream targets of Notch are short lived. Alternatively, Notch
could be activated by injury by acute ligand upregulation,
changes in local calcium (Rand et al., 2000), or a ligand-
independent mechanism. In either case, Notch signaling
affects not only growth cone initiation after injury but also has
profound effects on the eventual success of regeneration,
limiting both morphological and functional recovery after nerve
injury (Figures 2C and 2D).
Notch has multiple functions in neuronal development.
During early development, Notch signaling maintains neuronal
progenitors and inhibits neuronal differentiation (Louvi and
Artavanis-Tsakonas, 2006). After differentiation, Notch sig-
naling inhibits neurite extension in cultured vertebrate neurons
and in the neonatal mouse cortex (Berezovska et al., 1999;
Franklin et al., 1999; Redmond et al., 2000; Sestan et al.,
1999) and modulates axon guidance in Drosophila (Crowner
et al., 2003). Our results demonstrate that Notch’s function in
regulating the growth potential of neurons is not limited to
development. Rather, Notch signaling can function long after
development is complete and can act after nerve injury to
suppress axon regeneration.
EXPERIMENTAL PROCEDURES
C. elegans Strains
Animals were maintained on nematode growth medium agar plates with E. coli
OP50 as a source of food (Stiernagle, 2006). Temperature was controlled at
20C unless otherwise stated. Null mutations in lin-12 result in sterility, so
we characterized homozygous mutant progeny that segregated from
a balanced heterozygous strain. Maternal contributions of wild-type Notch/
lin-12 allow these mutants to survive and develop into viable adults. Many of
these adults rupture from their vulva; we used only normally sized, healthy
animals in these experiments. Strain names, genotypes, and complete data
with p values can be found in Tables S1–S3.
Axotomy
All experiments were performed in parallel with a matched control. L4-stage
hermaphrodites were mounted in a slurry of 0.1 mm diameter polystyrene
beads (Polysciences) or in 50 mM of the GABA agonist, muscimol, (Sigma
M1523) to immobilize the animals. No difference in regeneration rates was
observed between beads and muscimol: wild-type animals regenerated at
a similar rate under both conditions, and Notch signaling mutants had
increased regeneration under both conditions (data not shown). Commissures
in the tail region of the animal posterior to the vulva were severed (GABA
neurons: VD and DD; acetylcholine neurons: AS and DB). Commissures
were visualized with a Nikon Eclipse 80i microscope using a 1003 Plan ApoVC
lens (1.4 NA) and a Hamamatsu Orca camera. Selected axons were cut using
a Micropoint laser from Photonic Instruments (10 pulses, 20 Hz). Axotomized
animals were recovered to agar plates and remounted 18–24 hr later for
scoring. At least 30 axons were scored for most genotypes (2–3 cut axons
per animal); see Tables S1–S3. Only axons with a distal stump as evidence
of a complete cut were scored. Axons with a visible growth cone that had pro-
gressed past the cut site, and axons that had regenerated to the dorsal nerve
cord, were scored as positive. Axons with no growth or with only filopodial
extensions and no progression past the cut site were counted as negative.
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reconnection to the dorsal cord 24 hr after axotomy were scored as positive.
For growth cone initiation at 4 and 6 hr, axons with a growth cone were
scored as positive. 95% confidence intervals were calculated by the Wald
method, and two-tailed p values were calculated using Fisher’s exact test
(http://www.graphpad.com/quickcalcs/).
Functional Recovery
All visible GABA commissures (16/ animal) were severed in healthy wild-type
and lin-12(n137) gain-of-function L4-stage animals. Axotomized animals
were recovered onto fresh plates with food and probed on the nose 1 hr after
axotomy. At 1 hr after axotomy, all animals responded by shrinking and were
unable to initiate backward locomotion. Animals were scored at 24 hr after
axotomy into one of the following categories: (1) no backward movement
(shrink); (2) one or two body bends backward; or (3) three or more body bends
and efficient backing up, but not wild-type. No axotomized animals recovered
completely wild-type locomotion after axotomy.
Molecular Biology
Plasmids were assembled using Gateway recombination (Invitrogen). Entry
clones were generated using Phusion DNA polymerase (Finnzymes). Primers,
templates, and plasmid names are listed in Supplemental Experimental
Procedures.
Transgenics
Transgenic animals were obtained by microinjection as described (Mello
et al., 1991). Transgene name, content, and concentrations are listed in
Supplemental Experimental Procedures. For most strains, stable transgenic
lines were selected based on GFP expression in the pharyngeal muscles
from a Pmyo-2:GFP coinjection marker. For XE1291 wpEx107 lin-
12(n941)(III)/hT2(I;III), transgenics were selected based on mCherry expres-
sion in GABA neurons. For XE1271 wpEx102, transgenics were selected
based on mCherry expression in the cholinergic motor neurons. For XE1139
and XE1208, unc-32 rescued animals were picked based on wild-type
movement.
DAPT Injections
N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT)
was obtained from Tocris Bioscience (Cat. No. 2634) and prepared in
DMSO. This stock was diluted in M9 medium to a final concentration of
100 mM DAPT and 1% DMSO. The control solution contained 1% DMSO in
M9. Wild-type EG1285 oxIs12 or sel-12(ok2078); hop-1(ar179) (derived from
XE1207 balanced strain) hermaphrodites were axotomized at the L4 stage
(or 5 days post-L4 for the experiment in aged animals). Small numbers of
animals (10) were axotomized at one time to minimize timing errors. The
animals were promptly recovered to agar plates with food. Animals were
then mounted for injections either immediately or after a 2 hr delay. Injections
were performed into the pseudocoelom using standard microinjection tech-
niques. Injected animals were recovered to new agar plates and scored for
regeneration as previously described.
Fluorescence Quantification
Expression of the mCherry cebp-1 reporter (juEx1735) (Yan et al., 2009)
was analyzed in uninjured animals using an UltraVIEW VoX (PerkinElmer)
spinning disc confocal and a 403 CFI Plan Apo, NA 1.0 oil objective. Cell
body fluorescencewas quantified using Volocity (Improvision) and the average
fluorescence per cell body was used to calculate the mean. Twenty-one
wild-type (juEx1735) and 19 sup-17(n316); juEx1735 animals were analyzed,
and the average fluorescence intensity per animal was determined for each
genotype. See Table S3 for numbers and statistics.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three tables and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2011.11.017.ACKNOWLEDGMENTS
We thank Iva Greenwald, Anne Hart, and Yishi Jin for helpful discussions and
reagents and Daniel Colo´n-Ramos, Antonio Giraldez, and Mike Hurwitz for
comments on the manuscript. Work in the Hammarlund laboratory is sup-
ported by the Beckman Foundation, the Ellison Medical Foundation, and
National Institutes of Health grant R01NS066082 to M.H. Experiments were
designed by Rachid El Bejjani and Marc Hammarlund and were executed by
Rachid El Bejjani.
Accepted: November 8, 2011
Published: January 25, 2012
REFERENCES
Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. (1999). Notch signaling:
cell fate control and signal integration in development. Science 284, 770–776.
Atwal, J.K., Pinkston-Gosse, J., Syken, J., Stawicki, S., Wu, Y., Shatz, C., and
Tessier-Lavigne, M. (2008). PirB is a functional receptor for myelin inhibitors of
axonal regeneration. Science 322, 967–970.
Austin, J., and Kimble, J. (1989). Transcript analysis of glp-1 and lin-12, homol-
ogous genes required for cell interactions during development of C. elegans.
Cell 58, 565–571.
Berezovska, O., McLean, P., Knowles, R., Frosh, M., Lu, F.M., Lux, S.E., and
Hyman, B.T. (1999). Notch1 inhibits neurite outgrowth in postmitotic primary
neurons. Neuroscience 93, 433–439.
Chao, M.Y., Larkins-Ford, J., Tucey, T.M., and Hart, A.C. (2005). lin-12 Notch
functions in the adult nervous system of C. elegans. BMC Neurosci. 6, 45.
Christie, K.J., Webber, C.A., Martinez, J.A., Singh, B., and Zochodne, D.W.
(2010). PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult
peripheral axons. J. Neurosci. 30, 9306–9315.
Crowner, D., Le Gall, M., Gates, M.A., and Giniger, E. (2003). Notch steers
Drosophila ISNb motor axons by regulating the Abl signaling pathway. Curr.
Biol. 13, 967–972.
Dovey, H.F., John, V., Anderson, J.P., Chen, L.Z., de Saint Andrieu, P., Fang,
L.Y., Freedman, S.B., Folmer, B., Goldbach, E., Holsztynska, E.J., et al. (2001).
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in
brain. J. Neurochem. 76, 173–181.
Filbin, M.T. (2008). PirB, a second receptor for the myelin inhibitors of axonal
regeneration Nogo66, MAG, and OMgp: implications for regeneration in vivo.
Neuron 60, 740–742.
Fortini, M.E. (2009). Notch signaling: the core pathway and its posttranslational
regulation. Dev. Cell 16, 633–647.
Fournier, A.E., GrandPre, T., and Strittmatter, S.M. (2001). Identification of
a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409,
341–346.
Franklin, J.L., Berechid, B.E., Cutting, F.B., Presente, A., Chambers, C.B.,
Foltz, D.R., Ferreira, A., and Nye, J.S. (1999). Autonomous and non-autono-
mous regulation of mammalian neurite development by Notch1 and Delta1.
Curr. Biol. 9, 1448–1457.
Geling, A., Steiner, H., Willem, M., Bally-Cuif, L., and Haass, C. (2002). A
gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe
neurogenic phenotype in zebrafish. EMBO Rep. 3, 688–694.
Giniger, E. (1998). A role for Abl in Notch signaling. Neuron 20, 667–681.
Gordon, W.R., Arnett, K.L., and Blacklow, S.C. (2008). The molecular logic of
Notch signaling—a structural and biochemical perspective. J. Cell Sci. 121,
3109–3119.
Greenwald, I. (2005). LIN-12/Notch signaling in C. elegans. In WormBook,
The C. elegans Research Community, ed. 10.1895/wormbook.1.10.1, http://
www.wormbook.org.
Greenwald, I., and Seydoux, G. (1990). Analysis of gain-of-function mutations
of the lin-12 gene of Caenorhabditis elegans. Nature 346, 197–199.Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc. 277
Neuron
Notch Signaling Inhibits Axon RegenerationGreenwald, I.S., Sternberg, P.W., and Horvitz, H.R. (1983). The lin-12 locus
specifies cell fates in Caenorhabditis elegans. Cell 34, 435–444.
Hammarlund, M., Nix, P., Hauth, L., Jorgensen, E.M., and Bastiani, M. (2009).
Axon regeneration requires a conserved MAP kinase pathway. Science 323,
802–806.
Hassan, B.A., Bermingham, N.A., He, Y., Sun, Y., Jan, Y.N., Zoghbi, H.Y., and
Bellen, H.J. (2000). atonal regulates neurite arborization but does not act as
a proneural gene in the Drosophila brain. Neuron 25, 549–561.
Hunt-Newbury, R., Viveiros, R., Johnsen, R., Mah, A., Anastas, D., Fang, L.,
Halfnight, E., Lee, D., Lin, J., Lorch, A., et al. (2007). High-throughput in vivo
analysis of gene expression in Caenorhabditis elegans. PLoS Biol. 5, e237.
Jarriault, S., and Greenwald, I. (2005). Evidence for functional redundancy
between C. elegans ADAM proteins SUP-17/Kuzbanian and ADM-4/TACE.
Dev. Biol. 287, 1–10.
Jarriault, S., Brou, C., Logeat, F., Schroeter, E.H., Kopan, R., and Israel, A.
(1995). Signalling downstream of activated mammalian Notch. Nature 377,
355–358.
Lambie, E.J., and Kimble, J. (1991). Two homologous regulatory genes, lin-12
and glp-1, have overlapping functions. Development 112, 231–240.
Le Gall, M., De Mattei, C., and Giniger, E. (2008). Molecular separation of two
signaling pathways for the receptor, Notch. Dev. Biol. 313, 556–567.
Levitan, D., and Greenwald, I. (1995). Facilitation of lin-12-mediated signalling
by sel-12, a Caenorhabditis elegans S182 Alzheimer’s disease gene. Nature
377, 351–354.
Li, X., and Greenwald, I. (1997). HOP-1, a Caenorhabditis elegans presenilin,
appears to be functionally redundant with SEL-12 presenilin and to facilitate
LIN-12 and GLP-1 signaling. Proc. Natl. Acad. Sci. USA 94, 12204–12209.
Lieber, T., Kidd, S., Alcamo, E., Corbin, V., and Young, M.W. (1993).
Antineurogenic phenotypes induced by truncated Notch proteins indicate
a role in signal transduction and may point to a novel function for Notch in
nuclei. Genes Dev. 7, 1949–1965.
Louvi, A., and Artavanis-Tsakonas, S. (2006). Notch signalling in vertebrate
neural development. Nat. Rev. Neurosci. 7, 93–102.
McGee, A.W., and Strittmatter, S.M. (2003). The Nogo-66 receptor: focusing
myelin inhibition of axon regeneration. Trends Neurosci. 26, 193–198.
Mello, C.C., Kramer, J.M., Stinchcomb, D., and Ambros, V. (1991). Efficient
gene transfer in C.elegans: extrachromosomal maintenance and integration
of transforming sequences. EMBO J. 10, 3959–3970.
Ouellet, J., Li, S., and Roy, R. (2008). Notch signalling is required for both dauer
maintenance and recovery in C. elegans. Development 135, 2583–2592.
Park, K.K., Liu, K., Hu, Y., Smith, P.D., Wang, C., Cai, B., Xu, B., Connolly, L.,
Kramvis, I., Sahin, M., and He, Z. (2008). Promoting axon regeneration in the
adult CNS bymodulation of the PTEN/mTOR pathway. Science 322, 963–966.
Priess, J.R. (2005). Notch signaling in the C. elegans embryo. In WormBook,
The C. elegans Research Community, ed. 10.1895/wormbook.1.4.1, http://
www.wormbook.org.
Qiao, L., Lissemore, J.L., Shu, P., Smardon, A., Gelber, M.B., and Maine, E.M.
(1995). Enhancers of glp-1, a gene required for cell-signaling inCaenorhabditis
elegans, define a set of genes required for germline development. Genetics
141, 551–569.
Rand, M.D., Grimm, L.M., Artavanis-Tsakonas, S., Patriub, V., Blacklow, S.C.,
Sklar, J., and Aster, J.C. (2000). Calcium depletion dissociates and activates
heterodimeric notch receptors. Mol. Cell. Biol. 20, 1825–1835.278 Neuron 73, 268–278, January 26, 2012 ª2012 Elsevier Inc.Redmond, L., Oh, S.R., Hicks, C., Weinmaster, G., and Ghosh, A. (2000).
Nuclear Notch1 signaling and the regulation of dendritic development. Nat.
Neurosci. 3, 30–40.
Rossi, F., Gianola, S., and Corvetti, L. (2007). Regulation of intrinsic neuronal
properties for axon growth and regeneration. Prog. Neurobiol. 81, 1–28.
Schuske, K., Beg, A.A., and Jorgensen, E.M. (2004). The GABA nervous
system in C. elegans. Trends Neurosci. 27, 407–414.
Sestan, N., Artavanis-Tsakonas, S., and Rakic, P. (1999). Contact-dependent
inhibition of cortical neurite growth mediated by notch signaling. Science 286,
741–746.
Shih, IeM., and Wang, T.L. (2007). Notch signaling, gamma-secretase inhibi-
tors, and cancer therapy. Cancer Res. 67, 1879–1882.
Singh, K., Chao, M.Y., Somers, G.A., Komatsu, H., Corkins, M.E., Larkins-
Ford, J., Tucey, T., Dionne, H.M., Walsh, M.B., Beaumont, E.K., et al. (2011).
C. elegans Notch signaling regulates adult chemosensory response and larval
molting quiescence. Curr. Biol. 21, 825–834.
Smith, P.D., Sun, F., Park, K.K., Cai, B., Wang, C., Kuwako, K., Martinez-
Carrasco, I., Connolly, L., and He, Z. (2009). SOCS3 deletion promotes optic
nerve regeneration in vivo. Neuron 64, 617–623.
Solomon, A., Mian, Y., Ortega-Cava, C., Liu, V.W., Gurumurthy, C.B.,
Naramura, M., Band, V., and Band, H. (2008). Upregulation of the let-7
microRNA with precocious development in lin-12/Notch hypermorphic
Caenorhabditis elegans mutants. Dev. Biol. 316, 191–199.
Stiernagle, T. (2006) Maintenance ofC. elegans. In WormBook, The C. elegans
Research Community, ed. 10.1895/wormbook.1.101.1, http://www.
wormbook.org.
Struhl, G., Fitzgerald, K., and Greenwald, I. (1993). Intrinsic activity of the
Lin-12 and Notch intracellular domains in vivo. Cell 74, 331–345.
Tax, F.E., Thomas, J.H., Ferguson, E.L., and Horvitz, H.R. (1997). Identification
and characterization of genes that interact with lin-12 in Caenorhabditis
elegans. Genetics 147, 1675–1695.
Wen, C., Metzstein, M.M., and Greenwald, I. (1997). SUP-17, aCaenorhabditis
elegans ADAM protein related to Drosophila KUZBANIAN, and its role in
LIN-12/NOTCH signalling. Development 124, 4759–4767.
Wittenburg, N., Eimer, S., Lakowski, B., Ro¨hrig, S., Rudolph, C., and
Baumeister, R. (2000). Presenilin is required for proper morphology and
function of neurons in C. elegans. Nature 406, 306–309.
Yan, D., Wu, Z., Chisholm, A.D., and Jin, Y. (2009). The DLK-1 kinase promotes
mRNA stability and local translation inC. elegans synapses and axon regener-
ation. Cell 138, 1005–1018.
Yanik, M.F., Cinar, H., Cinar, H.N., Chisholm, A.D., Jin, Y., and Ben-Yakar, A.
(2004). Neurosurgery: functional regeneration after laser axotomy. Nature 432,
822.
Yiu, G., and He, Z. (2006). Glial inhibition of CNS axon regeneration. Nat. Rev.
Neurosci. 7, 617–627.
Yochem, J., and Greenwald, I. (1989). glp-1 and lin-12, genes implicated in
distinct cell-cell interactions in C. elegans, encode similar transmembrane
proteins. Cell 58, 553–563.
Yochem, J., Weston, K., and Greenwald, I. (1988). TheCaenorhabditis elegans
lin-12 gene encodes a transmembrane protein with overall similarity to
Drosophila Notch. Nature 335, 547–550.
Yoo, A.S., Bais, C., and Greenwald, I. (2004). Crosstalk between the EGFR and
LIN-12/Notch pathways in C. elegans vulval development. Science 303,
663–666.
